Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Sotera Health

I’m a Self-Made Millionaire: 5 Stocks You Should Consider Selling

Analysts can offer advice about what stocks to buy and sell, but sometimes the best guidance comes from people who built their fortunes through investments.

GOBankingRates

Top 3 Health Care Stocks That Could Blast Off In December

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Benzinga

Sotera Health Shows Rising Relative Price Performance; Still Shy Of Key Benchmark

A Relative Strength Rating upgrade for Sotera Health shows improving technical performance. Will it continue?

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Sotera Health Sees IBD RS Rating Rise To 72

A Relative Strength Rating upgrade for Sotera Health shows improving technical performance. Will it continue?

Investors Business Daily

Sotera Health Clears Technical Benchmark, Hitting 80-Plus RS Rating

Sotera Health sees its Relative Strength Rating reach the 80-plus level.

Investors Business Daily

Sotera Health Stock Earns 91 RS Rating

A Relative Strength Rating upgrade for Sotera Health shows improving technical performance.

Investors Business Daily

Impressed Tesla Stock Is Up 60%? 7 Stocks Leave It In The Dust

Think Tesla stock's 60% year-to-date gain is impressive? Other stocks, including a few in the S&P 500, are blowing its doors off.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago quarter.

Benzinga

Jury says Sterigenics should pay $363 million to Illinois woman for exposing her to cancer-causing ethylene oxide

Sterigenics, its parent company and a corporate predecessor should pay $363 million in damages for exposing a Willowbrook, Illinois, woman and thousands of others to cancer-causing ethylene oxide pollution, a Cook County jury decided Monday.

Chicago Tribune

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga

Sterigenics trial: $363 million verdict against Willowbrook company in first trial over toxic gas emissions

The verdict exceeded the $346 million that lawyers for plaintiff Sue Kamuda asked for in closing arguments Thursday against Sterigenics, parent company Sotera Health and its corporate predecessor Griffith Foods.

Chicago Sun-Times

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Stocks That Hit 52-Week Lows On Friday

During Friday's session, 41 companies made new 52-week lows.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022

Upgrades

Benzinga

Sotera Health's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, Sotera Health (NASDAQ:SHC) earned $30.64 million, a 14.88% increase from the preceding quarter. Sotera Health's sales decreased to $236.75 million, a 1.86% change since Q4.

Benzinga

Recap: Sotera Health Q1 Earnings

Sotera Health (NASDAQ:SHC) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:15 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Sotera Health Earnings Conference Call Is Coming Up, Here's What You Need To Know

Sotera Health (NASDAQ:SHC) will host a conference call at 09:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results.

Benzinga

Expert Ratings For Sotera Health

Sotera Health (NASDAQ:SHC) has observed the following analyst ratings within the last quarter:

Benzinga

Analyst Ratings For Sotera Health

Over the past 3 months, 5 analysts have published their opinion on Sotera Health (NASDAQ:SHC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Expert Ratings For Sotera Health

Within the last quarter, Sotera Health (NASDAQ:SHC) has observed the following analyst ratings:

Benzinga

Recap: Sotera Health Q4 Earnings

Sotera Health (NASDAQ:SHC) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:15 AM. Here's what investors need to know about the announcement.

Benzinga

Sotera Health Earnings Preview

Sotera Health (NASDAQ:SHC) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that Sotera Health will report an earnings per share (EPS) of $0.22.

Organisations

SP Global Market Intelligence

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.